News

Media contact:
Molly Bowen  

Suniti Solomon: India’s Preeminent HIV Researcher & Activist

Post Date: 
2023-05-31
Suniti Solomon
Dr. Suniti Solomon detected India’s first cases of HIV. She also founded YRG CARE & raised CIDI Co-director Dr. Sunil Solomon. Learn about her commitment to science & unwavering dedication to compassionate patient care.

India Research Partnership Commemorates World TB Day

Post Date: 
2023-04-14
Group Photo
World TB Day event in Pune includes a special street play, counseling sessions, and research and education discussions, aimed to engage the community in healthy approaches to TB treatment and prevention under this year’s World TB Day theme "Yes we can end TB."

Accelerating progress toward the end of AIDS in India

Post Date: 
2023-01-31
Accelerating progress toward the end of AIDS in India
The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV.

Accelerating progress toward the end of AIDS in India

Post Date: 
2023-01-31
Accelerating progress toward the end of AIDS in India
The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV.

Research in Action Awards 2022

Post Date: 
2022-11-14
Dr. Amita Gupta
TAG’s 2022 Research in Action Awards will honor activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C around the world. Check it out to see Amita Gupta, GKII Co-Chair, receive her award.

CIDI at the Union 2022

Post Date: 
2022-11-08
The Union Conference 2022
CIDI researchers and faculty will join the virtual Union Conference--check out our agenda!

CIDI Baltimore Launch Event

Post Date: 
2022-09-14
Group photo of CIDI staff
Did you miss CIDI’s Baltimore launch event? You can view the recorded proceedings!

Johns Hopkins Receives Award for Antimicrobial Resistance Detection and Infection Control Partnership in India

Post Date: 
2021-12-14
Johns Hopkins Receives Award for Antimicrobial Resistance Detection and Infection Control Partner
In a press release issued Tuesday, December 7, the U.S. Centers for Disease Control and Prevention (CDC) announced the launch of two global networks to address the rise of antimicrobial resistance and other healthcare threats.

Researchers Identify Biomarker that Heralds Poor Outcomes in TB Patients

Post Date: 
2021-11-09
Dr. Akshay Gupte and colleagues discovered that elevated IL-6 can predict poor treatment outcomes, showcasing a need for including IL-6 in clinical screenings.

Mentorship Award!

Post Date: 
2021-11-02
Gauri Dhumal and Neetal Nevrekar Receive PEER Grant Award
Gauri Dhumal and Neetal Nevrekar received the award from USAID’s Women in Science Mentoring Program for separate pilot projects that study better tuberculosis treatment methods. Nishi Suryavanshi is their mentor.

CURE ID Moves to Automated Data Collection in Light of COVID Pandemic

Post Date: 
2021-07-13
Dr. Matt Robinson
Drs. Matt Robinson is leading JHU efforts in this FDA program, and Robert Bollinger and Jane McKenzie-White helped launch it before COVID.

Innovation During Times of Change  |  2020 Annual Report

Post Date: 
2021-03-30
2020 Annual Report
2020 was a year like no other. Learn what CCGHE discovered in our Annual Report.

Research Update: TB Trials Conducted by JHU-India Team Will Shorten Drug-Susceptible TB Treatment for Children and Adults

Post Date: 
2020-12-07
Research Updated
Reporting from the virtual 51st Union Conference on Lung Health, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) announced promising findings from 2 TB trials

Super-spreading Events: Lessons from India on Containment of COVID-19, Co-Hosted by Johns Hopkins India Institute

Post Date: 
2020-11-09
Super-spreading Events
Join Dr. Jennifer Nuzzo for a conversation with Drs. Brian Wahl and Sanjay Mehendale on what we can learn from India about pandemic safety. Register now!

India's National Digital Health Mission and the Patient Data Revolution, Co-Hosted by the Johns Hopkins India Institute

Post Date: 
2020-10-07
Livestream
For decades, global health systems have been transitioning from paper to electronic health records to improve patient data accessibility, particularly to facilitate epidemiological study and preventive care.

NIH Awards Johns Hopkins Baltimore-Washington-India Trials Group $460,679 in Supplemental COVID-19 Funding

Post Date: 
2020-06-30
The supplement is leveraging existing HIV research infrastructure and personnel for DAIDS-sponsored COVID research

Pandemic Planning in Pune: Distributing Study Medication during COVID-19

Post Date: 
2020-04-23
Dr. Sandesh Patil
Dr. Sandesh Patil reports how the team in India ensured study participants received medication during the COVID-19 pandemic.

CCGHE at CROI 2020

Post Date: 
2020-03-04
CROI 2020
CCGHE is part of 17 presentations at this year's Conference of Retroviruses and Opportunistic Infections! Check out where we will be!

CCGHE Joins the Alliance of Artificial Intelligence in Healthcare

Post Date: 
2020-01-13
Dr. Robert Bollinger
“AAIH’s mission dovetails very well with our own work at Hopkins,” CCGHE Director Dr. Robert Bollinger noted.

CCGHE at the 2019 Union TB Conference

Post Date: 
2019-10-21
2019 Union World Conference on Lung Health
CCGHE researchers and faculty will be in Hyderbad for the Union Conference--check out our agenda!

Pages

New study aims for best strategy to find recurrent cases of Tuberculosis

Post Date: 
2023-09-15
Source: 
Indian Express
Counsellors visit patients ' homes
A novel trial is underway in Pune to provide evidence on how best to find people with recurrent Tuberculosis (TB) , so that they can be quickly linked to care.

Taking HIV Care Online

Post Date: 
2023-09-06
Source: 
Span Magazine
A sexual health manager at Safe Zindagi explains the HIV self-testing process to a client. (Photograph courtesy Safe Zindagi)
Safe Zindagi , an online portal funded by USAID and PEPFAR, provides HIV care and services to hard-to-reach populations in India.

Navigating Adolescence With HIV

Post Date: 
2023-09-06
Source: 
Span Magazine
USAID-supported Adolescent-Friendly Health Centers create a supportive youth-led community that can help HIV positive children navigate challenges. (Photograph courtesy ACCELERATE)
USAID, with support of PEPFAR , set up Adolescent-Friendly Health Centers through its flagship program, ACCELERATE, led by Johns Hopkins University School of Medicine, to support 10-17-year-old HIV positive adolescents with comprehensive health care and services.

Making HIV Care Accessible

Post Date: 
2023-09-06
Source: 
Span Magazine
TAAL (Treatment, Adherence, Advocacy and Literacy) was launched in 2006, as a peer-led community pharmacy to provide high-quality and affordable HIV diagnostics, treatment and peer counseling services to people living with HIV. In 2020, with support from USAID, TAAL transitioned from a community...

Turning the Tide for HIV-Affected Families

Post Date: 
2023-09-06
Source: 
Span Magazine
The orphans and vulnerable children program—which serves children and adolescents who are at risk of infection, live with HIV or with HIV-positive caregivers—provide peer-led and family-centric care. One such USAID project, ACCELERATE , implemented by John Hopkins University, works closely with...

Pune study shows ‘promising results’ in bid to prevent TB among those at most risk

Post Date: 
2023-08-01
Source: 
Indian Express
Woman showing a diagram to a patient
Interim results are “promising” and show that a short treatment regimen called “3HP” could pave the way in preventing TB.

How a Pune trial SHINEs light on shorter TB treatment for children

Post Date: 
2023-06-26
Source: 
The Indian Express
TB OPD at Sassoon hospital
Last year, based on SHINE research, the WHO strongly recommended shortening the TB treatment duration in non-severe paediatric TB cases from six-four months.

Paediatric TB: An Overview (India)

Post Date: 
2023-06-26
Source: 
Survivors Against TB
Paediatric TB: An Overview (India)
Video: Shedding Light on Pediatric TB in India

Research shows India can shorten tuberculosis treatment

Post Date: 
2023-06-13
Source: 
The Hindu
Vidya Mave and Aarti Kinikar with text: At this time, it is up to researchers to identify the best combinations of these new drugs that are highly efficacious, the least toxic, and can be easily implemented in programmatic settings.
Recent studies have found that the length of time tuberculosis patients need to stay on their regimen can be reduced from six to four months.

Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India

Post Date: 
2023-06-08
Source: 
CIDI
Mitr Clinic team
On Wednesday, June 7th, CIDI celebrated Pride Month at the event "Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India."

250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries

Post Date: 
2023-03-30
Source: 
Unitaid
Amita Gupta, MD, MHS
The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only taken for 28 days. This contribution is part of the Consortium’s ongoing efforts to end TB and improve global health outcomes.

BJ Government Medical College launches new study to assess TB, HIV, diabetes among pregnant women

Post Date: 
2023-03-23
Source: 
The Indian Express
Team photo
The launch of the study coincides with the World TB week. “Titled `PraGaTHi’, this study will explore how the changes in immunity due to pregnancy and GDM increase the risk of TB in pregnant and postpartum women.”

What next after shortened TB treatment fails in key trial?

Post Date: 
2023-03-13
Source: 
Spotlight
Vidya Mave
Dr. Vidya Mave discusses the pros and cons of shortened tuberculosis treatment with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ).

The Virus Hunters Trying to Prevent the Next Pandemic

Post Date: 
2022-08-04
Source: 
Time
Sunil Solomon
Sunil Solomon: “Each of us brings a different skill set... The coalition is focused on translating what all of us find for clinical relevance to make sure that whatever we are doing is tailored toward improving the public’s health.”

Monkeypox: ‘No plans yet to get vaccine,’ says health ministry

Post Date: 
2022-07-26
Source: 
The Hindustan Times
Amita Gupta headshot
Dr. Amita Gupta spoke to the Hindustan Times about the monkeypox outbreak. “Currently mass vaccination is not required. Instead, priority is recommended for contacts of cases..."

The paradox of antimicrobial resistance in India

Post Date: 
2022-06-15
Source: 
Fogarty International Center
Dr. Matt Robinson
Fogarty International Center: Dr. Matt Robinson: "So sometimes you provide treatment for the worst possible scenario,” like prescribing antibiotics before identifying the cause of illness.

COVID virus can evolve in animals, spawn variants that can jump back to humans: Scientists

Post Date: 
2022-04-28
Source: 
Business Today
decorative: covid virus
Last week, the Centers for Disease Control and Prevention (CDC) confirmed that at least four people in Michigan, US, were infected with a version of the coronavirus observed mostly in minks during the first year of the pandemic.

Gauri Dhumal featured in Scholar Spotlight

Post Date: 
2022-04-28
Source: 
Weill Cornell Medicine Center for Global Health
Gauri Dhumal headshot
PDF: Dr. Gauri Dhumal was interviewed for the Weill Cornell Medicine Center for Global Health's Female Global Scholars newsletter. It is part of the Women In Global Health Research Initiative.

CAB Spotlight - Vijaya Jori

Post Date: 
2022-04-01
Source: 
ACTG Newsletter
Vijaya Jori
Community Advisory Boards are key members of research programs. The ACTG Newsletter features Vijaya Jori of the JHU-BJGMC CAB!

Alcohol reduction study in TB and HIV persons to commence in April in Pune

Post Date: 
2022-03-28
Source: 
The Indian Express
Nishi Suryavanshi
Dr. Nishi Suryavanshi: "We have contextualized the intervention to Indian settings and termed it as `HATHI’ intervention."

Pages

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

Post Date: 
2023-04-12
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...

Clone of Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

Post Date: 
2023-04-12
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally

Post Date: 
2022-08-04
Chaisson headshot; USAID Awards Johns Hopkins Medicine, Partners, Up to $200 Million for Global TB R
To address the global burden of TB, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by USAID for the SMART4TB project.

Gupta Named Director of the Division of Infectious Diseases

Post Date: 
2022-01-24
Dr. Amita Gupta
Congratulation on this amazing achievement! Dr.. Amita Gupta will be our next director of the Division of Infectious Diseases effective immediately.

CDC Launches Two Global Networks, Awards $22 Million to Combat Antimicrobial Resistance and Infectious Diseases

Post Date: 
2021-12-07
Dr. Matt Robinson
Dr. Matt Robinson’s collaboration with Indian partners on this CDC-funded effort builds on years of work on antimicrobial resistance.

Research Story Tip: Grants, Management Roles Keep Johns Hopkins A Leader In Hiv/Aids Clinical Trial Research

Post Date: 
2020-12-08
Research Story Tip
Researchers at Johns Hopkins Medicine learned that they now have an enhanced opportunity to help move the world toward a day when that observance is rendered obsolete.

Johns Hopkins Researchers Publish COVID-19 ‘Prediction Model’

Post Date: 
2020-09-23
Johns Hopkins News New COVID study findings published in The Annals of Internal Medicine are highlighted

Research Story Tip: International Johns Hopkins Study Says Broad Measures Needed to Prevent TB Spread in India

Post Date: 
2020-08-06
Dr. Mandar Paradkar
Johns Hopkins News Release: News release highlights study findings published in PLOS One by Dr. Mandar Paradkar and colleagues.

Study Shows Mobile Health, Video Technology, Influence Behavior of Affected Populations

Post Date: 
2020-07-09
Dr. Nishi Suryavanshi
Johns Hopkins News Release: Dr. Suryavanshi discusses her study on mobile health and technology training for improving care among HIV+ pregnant and post-partum women and their babies

In Women with HIV, TB Preventive Therapy Poses Greater Risk in Pregnancy than Postpartum

Post Date: 
2019-10-02
NIH Press Release: NIH announces NEJM published findings from the TB APPRISE trial, led by Dr. Amita Gupta

NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB

Post Date: 
2019-06-25
Tuberculosis bacteria
NIH Press Release : NIH announces a large international clinical trial to prevent multidrug-resistant TB in children, adolescents, and adults who live with someone who has MDR-TB. CCGHE's Dr. Amita Gupta is a protocol chair.

National Institutes of Health Awards emocha Mobile Health $1 Million for Multi-State Study

Post Date: 
2018-08-29
emocha-logo
Bob Bollinger: "It is critical for patients to take tuberculosis medication as prescribed, and research supports new adherence strategies. . . "

One-Month Tuberculosis Prophylaxis as Effective as Nine-Month Regimen for People Living with HIV

Post Date: 
2018-03-05
The Indo-JHU Clinical Research Partnership participated in this important study that could change TB prevention for people living with HIV.

Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting

Post Date: 
2018-03-01
Newswise — Amita Gupta, M.D., deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University School of Medicine, will present a multicounty study of preventive treatment for tuberculosis (TB) in HIV-infected pregnant and postpartum women—...

emocha Named to 2018 Top 10 Most Innovative Companies in Health by Fast Company

Post Date: 
2018-02-20
The Most Innovative Companies list recognizes pioneering companies across 36 categories, from health to artificial intelligence to wellness.

Mobile Health and Wellness Clinic Debuts in Pune for Clinical Research and Community-Based Care

Post Date: 
2016-07-25
The Maryland-based health care informatics company CTIS and its founders, Raj and Bharti Shah, have collaborated with the Johns Hopkins Center for Clinical Global Health Education and Byramjee Jeejeebhoy Government Medical College to equip and dispatch a custom-designed mobile health care services...

Proactively treating HIV patients at risk for tuberculosis with multidrug TB therapy doesn’t save more lives

Post Date: 
2016-03-17
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS...